Stoke Therapeutics Inc buy Guggenheim
Start price
07.02.26
/
50%
€26.60
Target price
07.02.27
€50.81
Performance (%)
9.77%
Price
13.03.26
€29.20
Summary
This prediction is currently active. With a performance of 9.77%, the BUY prediction by Guggenheim for Stoke Therapeutics Inc is trending in the right direction. This prediction currently runs until 07.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -1.351% | -1.351% |
| iShares Core DAX® | -1,10 % | -6,08 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % |
| iShares S&P 500 | -0,06 % | 0,88 % |
Comments by Guggenheim for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for STOK provided by MarketBeat